Electromed (ELMD) Competitors

Electromed (NYSE:ELMD) and Embecta (NASDAQ:EMBC) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their media sentiment, dividends, institutional ownership, earnings, valuation, community ranking, profitability, analyst recommendations and risk.

Which has more volatility and risk, ELMD or EMBC?

Electromed has a beta of 0.46, indicating that its stock price is 54% less volatile than the S&P 500. Comparatively, Embecta has a beta of 1.24, indicating that its stock price is 24% more volatile than the S&P 500.

Which has stronger valuation & earnings, ELMD or EMBC?

Embecta has higher revenue and earnings than Electromed. Embecta is trading at a lower price-to-earnings ratio than Electromed, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Electromed	$59.63M	2.94	$5.15M	$0.79	26.42
Embecta	$1.08B	0.67	$78.30M	$0.90	13.72

Is ELMD or EMBC more profitable?

Electromed has a net margin of 11.34% compared to Embecta's net margin of 5.25%. Electromed's return on equity of 15.71% beat Embecta's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Electromed	11.34%	15.71%	13.37%
Embecta	5.25%	-19.22%	11.92%

Do insiders & institutionals believe in ELMD or EMBC?

40.8% of Electromed shares are held by institutional investors. Comparatively, 93.8% of Embecta shares are held by institutional investors. 14.0% of Electromed shares are held by company insiders. Comparatively, 0.4% of Embecta shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Does the MarketBeat Community favor ELMD or EMBC?

Electromed received 24 more outperform votes than Embecta when rated by MarketBeat users. Likewise, 92.59% of users gave Electromed an outperform vote while only 5.56% of users gave Embecta an outperform vote.

Company	Underperform	Outperform
Electromed	Outperform Votes 25 92.59%	Underperform Votes 2 7.41%
Embecta	Outperform Votes 1 5.56%	Underperform Votes 17 94.44%

Do analysts rate ELMD or EMBC?

Electromed presently has a consensus price target of $38.00, suggesting a potential upside of 82.08%. Embecta has a consensus price target of $20.33, suggesting a potential upside of 64.64%. Given Electromed's stronger consensus rating and higher possible upside, equities research analysts clearly believe Electromed is more favorable than Embecta.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Electromed	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	1 Strong Buy rating(s)	4.00
Embecta	0 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.33

Does the media refer more to ELMD or EMBC?

In the previous week, Electromed and Electromed both had 5 articles in the media. Embecta's average media sentiment score of 1.38 beat Electromed's score of 1.29 indicating that Embecta is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Electromed	3 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Embecta	4 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Electromed beats Embecta on 11 of the 18 factors compared between the two stocks.